McGlone Suttner Wealth Management Inc. Has $655,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

McGlone Suttner Wealth Management Inc. grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,245 shares of the healthcare conglomerate’s stock after buying an additional 33 shares during the quarter. McGlone Suttner Wealth Management Inc.’s holdings in UnitedHealth Group were worth $655,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. Keebeck Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 11.6% during the 2nd quarter. Keebeck Wealth Management LLC now owns 10,788 shares of the healthcare conglomerate’s stock valued at $5,185,000 after buying an additional 1,122 shares during the last quarter. Ascension Capital Advisors Inc. acquired a new stake in UnitedHealth Group in the 3rd quarter worth approximately $216,000. Physician Wealth Advisors Inc. acquired a new stake in UnitedHealth Group in the 3rd quarter worth approximately $207,000. Bartlett & Co. LLC lifted its holdings in UnitedHealth Group by 5.7% in the 3rd quarter. Bartlett & Co. LLC now owns 164,353 shares of the healthcare conglomerate’s stock worth $82,865,000 after purchasing an additional 8,873 shares during the last quarter. Finally, Great Valley Advisor Group Inc. lifted its holdings in UnitedHealth Group by 5.8% in the 3rd quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock worth $17,292,000 after purchasing an additional 1,884 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded up $1.60 on Thursday, reaching $494.70. The company’s stock had a trading volume of 3,805,551 shares, compared to its average volume of 4,097,774. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. The company has a market cap of $456.08 billion, a price-to-earnings ratio of 20.70, a PEG ratio of 1.34 and a beta of 0.54. The business’s fifty day moving average price is $503.10 and its 200 day moving average price is $518.61. UnitedHealth Group Incorporated has a twelve month low of $445.68 and a twelve month high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. During the same quarter in the previous year, the firm earned $5.34 earnings per share. The business’s revenue was up 14.1% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.54%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on UNH. Stephens reaffirmed an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 8th. HSBC reaffirmed a “reduce” rating and issued a $480.00 price target (down from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $596.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 29th. Oppenheimer restated an “outperform” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Finally, Bank of America restated a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. One research analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $579.33.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.